Latest Schedule 13D activist filings
NYSE
SCHEDULE: Uber Sells Aurora Innovation Stake
Uber Technologies has sold 67.5 million shares of Aurora Innovation, reducing its stake to 15.6% in a block sale transaction.
NASDAQ
SCHEDULE: Uber Sells Aurora Innovation Stake
Uber Technologies has sold 67.5 million shares of Aurora Innovation, reducing its stake to 15.6% in a block sale transaction.
NYSE
Stephanie Foglia and a related trust have amended their Schedule 13D filing to report a combined beneficial ownership of 19.89% in Mistras Group, Inc.
NASDAQ
Kaufman Kapital LLC has sold a significant portion of its BranchOut Food Inc. common stock holdings in a privately negotiated block transaction.
NASDAQ
Veradace Partners LP, a significant shareholder, has withdrawn director nominations and announced its intent to withhold votes from current Repay Holdings Corporation directors, citing governance concerns and dissatisfaction with recent strategic decisions.
AMEX
Saba Capital Management, L.P. has amended its Schedule 13D filing, reporting a beneficial ownership of 4.71% in Clough Global Equity Fund following recent transactions.
NASDAQ
A group of investors has disclosed a combined 6.3% beneficial ownership in Citizens Community Bancorp Inc., citing undervalued stock and investment purposes.
KGPLA Holdings LLC and Michael Komaransky have jointly filed a Schedule 13D, disclosing beneficial ownership of 1,798,500 shares of BNB Plus Corp. common stock, representing 19.9% of the outstanding shares, acquired through a private placement of Series B-1 Convertible Preferred Stock.
NYSE
BNDES and its subsidiary BNDESPAR have reduced their combined beneficial ownership of Petrobras preferred shares to 16.83% following open market sales.
VRMMQ
Vroom, INCVroom, Inc. has entered into an agreement to issue up to $22 million in senior secured convertible notes due 2032 to Mudrick Capital Management.
NASDAQ
Tyler White has fully divested his stake in Hub Cyber Security Ltd., selling all previously held ordinary shares.
NASDAQ
Van Herk Investments B.V. announced its intention to vote against key share capital increase and authorization proposals at ProQR Therapeutics N.V.'s upcoming Annual General Meeting, citing concerns over potential dilution and governance.
NASDAQ
DOMO
Domo, INCRPD Fund Management LLC and associated entities have reported transactions in DOMO, INC. Class B Common Stock, adjusting their beneficial ownership to 9.87%.
Theodore Ralston has amended his Schedule 13D filing to report beneficial ownership of 2,202,859 shares of CitroTech Inc. common stock, representing approximately 9.82% of the outstanding shares.
NASDAQ
FONR
Fonar CORPFONAR Corporation announced the completion of its merger, resulting in the delisting and deregistration of its common stock.
NYSE
Saba Capital Management, L.P. has filed an amendment to its Schedule 13D, reporting a significant stake in BlackRock ESG Capital Allocation Term Trust and detailing recent trading activity.
NYSE
NVRI
Enviri CORPD. E. Shaw & Co., L.P. and its affiliates have amended their Schedule 13D filing to report no beneficial ownership of Enviri Corporation common stock following a business separation.
NASDAQ
STARTEEPO Invest and Frantisek Bostl report aggregated beneficial ownership of 6.22% in Xerox Holdings Corp following recent share and option transactions.
NASDAQ
ELAB
Elevai Labs INCSCHEDULE: PMGC Holdings Inc. Stakeholder Filing
Graydon Bensler and GB Capital Ltd. jointly file Schedule 13D, reporting a 7.40% stake in PMGC Holdings Inc. through stock and options.
NASDAQ
ELAB
Elevai Labs INCPMGC Holdings Inc. has filed an amendment to its Schedule 13D, detailing beneficial ownership changes and option grants to Northstrive Companies Inc.
NASDAQ
Forager Fund, L.P. announced its intention to withhold votes from all directors at Repay Holdings Corp.'s upcoming annual meeting, citing governance concerns and a lack of substantive engagement.
NYSE
Cevian Capital II GP Ltd has increased its beneficial ownership of Smith & Nephew plc ordinary shares to 11.88%, acquiring over 101 million shares for approximately $1.4 billion.
NYSE
Wolf Pen Branch, LP and its general partner, Wolf Pen Branch GP, LLC, have amended their Schedule 13D filing to reflect an increased beneficial ownership of Brown-Forman Corporation's Class A Common Stock, now representing 60.3% of the outstanding shares.
OQB
Scott M. Pittman amends Schedule 13D regarding Nuo Therapeutics, detailing loan agreements and warrant issuances.
NYSE
Franklin Resources Inc. and its subsidiary BSP Fund HoldCo report beneficial ownership of 75,000 Class I Shares in Franklin BSP Lending Fund, representing 81.5% of outstanding shares.
NASDAQ
Psyence Labs Ltd. has filed a Schedule 13D, revealing beneficial ownership of 1,146,159 common shares, representing 30.05% of Psyence Biomedical Ltd., acquired through a share-for-share exchange.
AMEX
Star Equity Fund, a significant shareholder, has nominated Rick Coleman for GEE Group's board and called for the removal of two incumbent directors.
NASDAQ
QRVO
Qorvo, INCStarboard Value LP has reduced its stake in Qorvo to 6.4% after selling 1.9 million shares on June 2, 2026.
NASDAQ
NorthStrive Fund II LP and Manager Braeden Lichti have liquidated their entire stake in Bluejay Diagnostics, Inc., marking a complete exit from the company.
NASDAQ
Braeden Lichti and Northstrive Fund II LP have filed an exit notice confirming the sale of their entire stake in Bluejay Diagnostics, Inc.